Default company panoramic image

CelaCare Technologies, Inc.

Specialty pharmaceutical and biotechnology company engaged in development of novel antimicrobial topical and oral formulations

  • Stage Product In Development
  • Industry Biotechnology
  • Location Dallas, TX, USA
  • Currency USD
  • Founded January 2013
  • Employees 3
  • Incorporation Type C-corp
  • Website

Company Summary

CelaCare Technologies, Inc. is an early-stage Harding University spin-out specialty pharmaceutical and biotechnology company. The company is engaged in the development of a portfolio of novel products primarily focused on mucosal and topical therapy markets valued at greater than $25B in the U.S. Broad patent protection protects the company's Innovative technology. Importantly, the company is led by experienced management and advisors.


  • 758af32b d82f 4627 b556 1490dbb59933
    President and CEO

    Dr. Kenneth Yates serves as president and CEO. He has more than 25 years of industry experience spanning R&D and management, including significant experience in wound and oral care product development. Dr. Yates previously served as president of DelSite Biotechnologies and currently is chair of the department of pharmaceutical sciences at Harding University College of Pharmacy. Dr. Yates also is a director for Piedmont Pharmaceuticals, LLC.

  • 5da56b3a 69ea 47da 857a 5bfcaef8e58e
    Vice President Specialty Pharmacy and Clinical Affairs

    Dr. Ginger Lowrie has served in various clinical, research, and pharmaceutical areas over the past 25 years. She has served as a Heme/Onc medical science liasion for GlaxoSmithKline and support for investigator sponsored trials. Dr. Lowrie has 17+ years of Pharmacy experience where she opened and consulted for multiple ambulatory surgery and specialty pharmacies and has experience with managed care payers, DOD, and the VA in multiple states.

Previous Investors

  • Default avatar